The store will not work correctly when cookies are disabled.
4-cyano-N-(1,2,8-trihydroxy-9-oxo-9H-xanthen-3-yl)benzenesulfonamide
ID: ALA4226616
PubChem CID: 145969948
Max Phase: Preclinical
Molecular Formula: C20H12N2O7S
Molecular Weight: 424.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1ccc(S(=O)(=O)Nc2cc3oc4cccc(O)c4c(=O)c3c(O)c2O)cc1
Standard InChI: InChI=1S/C20H12N2O7S/c21-9-10-4-6-11(7-5-10)30(27,28)22-12-8-15-17(20(26)18(12)24)19(25)16-13(23)2-1-3-14(16)29-15/h1-8,22-24,26H
Standard InChI Key: FNPJGKDSSRCXQC-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
29.5386 -13.0751 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9513 -13.7849 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.3597 -13.0726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2791 -12.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2779 -13.7873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9860 -14.1962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9842 -12.5589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6928 -12.9641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6916 -13.7893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4017 -14.2006 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.4041 -12.5503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1187 -12.9662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1175 -13.7872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8268 -14.1971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5378 -13.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5351 -12.9628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8252 -12.5566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4041 -11.7331 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8229 -11.7395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2414 -12.5516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2461 -14.1946 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6615 -14.1926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9817 -11.7417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6605 -15.0094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3699 -15.4170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0790 -15.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0743 -14.1825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3643 -13.7787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7870 -15.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4963 -15.8161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 11 1 0
9 10 1 0
10 13 1 0
12 11 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 18 2 0
17 19 1 0
16 20 1 0
15 21 1 0
21 2 1 0
2 22 1 0
7 23 1 0
22 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 22 1 0
29 30 3 0
26 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 424.39 | Molecular Weight (Monoisotopic): 424.0365 | AlogP: 2.74 | #Rotatable Bonds: 3 |
Polar Surface Area: 160.86 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.60 | CX Basic pKa: ┄ | CX LogP: 4.34 | CX LogD: 3.51 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.29 | Np Likeness Score: -0.22 |
References
1. Wang P, Jiang L, Cao Y, Zhang X, Chen B, Zhang S, Huang K, Ye D, Zhou L.. (2018) Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation., 26 (8): [PMID:29530347] [10.1016/j.bmc.2018.02.044] |